PTGX ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/5/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)2.47
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)213.47M
Protagonist Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Protagonist Therapeutics Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Protagonist Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Protagonist Therapeutics Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Protagonist Therapeutics Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
PTGX ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
PTGX FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-2.05-145.80%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)46.02M-89.41%
Protagonist Therapeutics Inc(PTGX) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | 2.47/2.08 | 213.47M/203.76M | 18.62% | 4.77% |
| 5/5/2026 | 03/2026 | 0.06/-0.53 | 56.37M/16.27M | 110.91% | 246.39% |
| 2/25/2026 | 12/2025 | -0.69/-0.49 | 7.44M/8.93M | -41.88% | -16.68% |
| 11/6/2025 | 09/2025 | -0.62/-0.64 | 4.71M/3.64M | 3.46% | 29.58% |
| 8/6/2025 | 06/2025 | -0.55/-0.58 | 5.55M/6.81M | 5.35% | -18.51% |
| 5/6/2025 | 03/2025 | -0.19/-0.23 | 28.32M/30.44M | 19.90% | -6.97% |
| 2/21/2025 | 12/2024 | 2.11/0.32 | 170.64M/50.35M | 557.84% | 238.88% |
| 11/7/2024 | 09/2024 | -0.54/-0.61 | 4.67M/2.07M | 11.50% | 125.69% |